BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

InDevR to Collaborate With Scientists at the Centers for Disease Control and Prevention (CDC) to Develop New Influenza Virus Surveillance Assay


5/11/2010 1:54:02 PM

BOULDER, CO--(Marketwire - May 11, 2010) - InDevR, developer of advanced life science products, announced its collaboration with scientists in the Influenza Division of the Centers for Disease Control and Prevention (CDC) in Atlanta to develop a unique influenza microarray assay.

InDevR and CDC scientists are working to develop a low density microarray capable of screening influenza A viruses for genetic reassortment. The microarray will be coupled with InDevR's inexpensive, compact ampliPHOX™ colorimetric detection system. This simple yet powerful microarray assay has the potential to enhance influenza surveillance efforts around the globe by providing an affordable tool for public health scientists that do not have access to full genome sequencing. Enabling point of service screening will help to more efficiently track the emergence of viruses like the swine origin H1N1, where genetic mixing occurred between influenza viruses adapted to different species. Funded by an internal CDC grant, the microarray will be developed over the next two years.

"We are excited about this collaboration with CDC that will leverage our combined experience with low-density microarray development, CDC's expertise in influenza surveillance, and InDevR's unique new ampliPHOX colorimetric detection technology. This compelling combination of technologies could greatly enhance global influenza surveillance efforts, which in turn, will provide essential and time-critical information for vaccine preparation," said Dr. Kathy Rowlen, InDevR's co-founder and CEO.

About InDevR
InDevR is a privately held company that develops advanced life science instrumentation and assays for analysis of viruses and other microorganisms. InDevR intends to revolutionize microbiological analysis with affordable, easy-to-use instrumentation and assays that deliver reliable results in less time than required for traditional methods. Designed for application in fields ranging from vaccine development to surveillance of pathogens, InDevR's products streamline microbiological analysis. More information about InDevR's products and services can be found at www.indevr.com.


Contact:
Erica Dawson
Email Contact
303-402-9100



Read at BioSpace.com

   
Influenza

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES